Zynex EBITDA Margin 2010-2024 | ZYXI
Zynex EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2024-06-30 | $0.19B | $0.02B | 7.73% |
2024-03-31 | $0.19B | $0.02B | 8.47% |
2023-12-31 | $0.18B | $0.02B | 8.15% |
2023-09-30 | $0.19B | $0.02B | 12.37% |
2023-06-30 | $0.18B | $0.02B | 12.92% |
2023-03-31 | $0.17B | $0.02B | 14.12% |
2022-12-31 | $0.16B | $0.03B | 16.35% |
2022-09-30 | $0.15B | $0.03B | 18.00% |
2022-06-30 | $0.14B | $0.03B | 20.28% |
2022-03-31 | $0.14B | $0.03B | 20.44% |
2021-12-31 | $0.13B | $0.02B | 18.46% |
2021-09-30 | $0.12B | $0.02B | 12.93% |
2021-06-30 | $0.10B | $0.01B | 7.92% |
2021-03-31 | $0.09B | $0.01B | 8.99% |
2020-12-31 | $0.08B | $0.01B | 15.00% |
2020-09-30 | $0.07B | $0.01B | 19.12% |
2020-06-30 | $0.06B | $0.01B | 23.33% |
2020-03-31 | $0.05B | $0.01B | 25.49% |
2019-12-31 | $0.05B | $0.01B | 26.67% |
2019-09-30 | $0.04B | $0.01B | 27.50% |
2019-06-30 | $0.04B | $0.01B | 30.56% |
2019-03-31 | $0.03B | $0.01B | 32.35% |
2018-12-31 | $0.03B | $0.01B | 34.38% |
2018-09-30 | $0.03B | $0.01B | 38.71% |
2018-06-30 | $0.03B | $0.01B | 40.00% |
2018-03-31 | $0.03B | $0.01B | 40.74% |
2017-12-31 | $0.02B | $0.01B | 39.13% |
2017-09-30 | $0.02B | $0.01B | 33.33% |
2017-06-30 | $0.02B | $0.00B | 26.67% |
2017-03-31 | $0.01B | $0.00B | 15.38% |
2016-12-31 | $0.01B | $0.00B | 15.38% |
2016-09-30 | $0.01B | 0 | 0.00% |
2016-06-30 | $0.01B | $-0.00B | -8.33% |
2016-03-31 | $0.01B | $-0.00B | -8.33% |
2015-12-31 | $0.01B | $-0.00B | -16.67% |
2015-09-30 | $0.01B | 0 | 0.00% |
2015-06-30 | $0.01B | 0 | 0.00% |
2015-03-31 | $0.01B | $-0.01B | -50.00% |
2014-12-31 | $0.01B | $-0.01B | -50.00% |
2014-09-30 | $0.01B | $-0.01B | -81.82% |
2014-06-30 | $0.01B | $-0.01B | -83.33% |
2014-03-31 | $0.02B | $-0.01B | -43.75% |
2013-12-31 | $0.02B | $-0.01B | -28.57% |
2013-09-30 | $0.03B | $-0.00B | -6.90% |
2013-06-30 | $0.03B | 0 | 0.00% |
2013-03-31 | $0.04B | $0.00B | 7.69% |
2012-12-31 | $0.04B | $0.00B | 10.00% |
2012-09-30 | $0.04B | $0.01B | 12.82% |
2012-06-30 | $0.04B | $0.01B | 13.16% |
2012-03-31 | $0.04B | $0.01B | 13.89% |
2011-12-31 | $0.03B | $0.00B | 11.76% |
2011-09-30 | $0.03B | $0.00B | 9.68% |
2011-06-30 | $0.03B | $0.00B | 10.34% |
2011-03-31 | $0.03B | $0.00B | 7.41% |
2010-12-31 | $0.03B | $0.00B | 8.00% |
2010-09-30 | $0.02B | $0.00B | 8.70% |
2010-06-30 | $0.02B | $0.00B | 9.52% |
2010-03-31 | $0.02B | $0.00B | 15.79% |
2009-12-31 | $0.02B | $0.00B | 22.22% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.264B | $0.184B |
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
Stryker (SYK) | United States | $139.112B | 32.51 |
Boston Scientific (BSX) | United States | $123.274B | 37.54 |
Medtronic (MDT) | Ireland | $114.744B | 17.07 |
EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
ResMed (RMD) | United States | $35.702B | 31.43 |
Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
Terumo (TRUMY) | Japan | $28.562B | 40.34 |
Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
Baxter (BAX) | United States | $19.774B | 13.41 |
Insulet (PODD) | United States | $16.665B | 70.11 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
ICU Medical (ICUI) | United States | $4.428B | 42.25 |
TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
Haemonetics (HAE) | United States | $3.842B | 19.01 |
Neogen (NEOG) | United States | $3.799B | 39.84 |
Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
Envista Holdings (NVST) | United States | $3.324B | 17.73 |
QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
InMode (INMD) | Israel | $1.490B | 9.49 |
Warby Parker (WRBY) | United States | $1.483B | 0.00 |
AtriCure (ATRC) | United States | $1.403B | 0.00 |
Owens & Minor (OMI) | United States | $1.237B | 9.55 |
BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
Evolus (EOLS) | United States | $1.037B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Quanterix (QTRX) | United States | $0.594B | 0.00 |
Surmodics (SRDX) | United States | $0.562B | 119.39 |
ZimVie (ZIMV) | United States | $0.468B | 43.49 |
VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
Valneva SE (VALN) | France | $0.419B | 0.00 |
Jin Medical (ZJYL) | China | $0.411B | 0.00 |
Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
Cerus (CERS) | United States | $0.339B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
Biote (BTMD) | United States | $0.331B | 15.27 |
OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
Omeros (OMER) | United States | $0.234B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
MacroGenics (MGNX) | United States | $0.213B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.172B | 71.33 |
Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
Brainsway (BWAY) | Israel | $0.137B | 163.80 |
TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
Veru (VERU) | United States | $0.117B | 0.00 |
Fonar (FONR) | United States | $0.110B | 11.15 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
InterCure (INCR) | Israel | $0.085B | 14.31 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Safety Shot (SHOT) | United States | $0.076B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
Exagen (XGN) | United States | $0.050B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.48 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |